Elevation Wealth Partners’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Elevation Wealth Partners's BMY Position: Q3 2026 in Review
Elevation Wealth Partners reduced its Bristol-Myers Squibb (BMY) stake by 1.8% in Q3 2026, selling an estimated $1.58K and leaving 1,392 shares worth $86.9K. The position accounts for 0.02% of the portfolio, ranked #228.
Elevation Wealth Partners first reported a position in BMY in Q1 2023 and has held it in 15 quarters since. 1,520 funds tracked by Wall St. Rank hold BMY as of Q3 2026.
- Elevation Wealth Partners held 1,392 shares of Bristol-Myers Squibb worth $86.9K as of Q3 2026.
- Elevation Wealth Partners sold 25 Bristol-Myers Squibb shares in Q3 2026, an estimated $1.58K.
- Bristol-Myers Squibb made up 0.02% of Elevation Wealth Partners's portfolio in Q3 2026, its #228 holding.
- Elevation Wealth Partners first reported a position in Bristol-Myers Squibb in Q1 2023 and has held it in 15 quarters since.
- 1,520 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.
Based on Elevation Wealth Partners's 13F filing for Q3 2026, filed 7 Oct 2026.